Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 6Terminated 2Recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Spinal Cord Compression 1Pancreatitis 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Duodenal Neoplasms 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Pantoprazole × Clear all
NCT05251233 2025-05-06

Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy

Washington University School of Medicine

Phase 2 Terminated
56 enrolled 11 charts
Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms, Pancreatitis

NCT02167633 2021-03-11

Stereocord

Rigshospitalet, Denmark

Phase NA Terminated
10 enrolled

Neoplasm Metastasis, Spinal Cord Compression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡